Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBA-RAKI: Ivabradine for Acute Heart Rate Control in Severe Burn Patients
jRCTs031240390Active, not recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ivabradine in burn injury, hypermetabolic response to burn injury (HRBI) and tachyarrhythmia, sponsored by Japan Society for the Promotion of Science. Primary endpoint: Frequency of hypotension. Started Mar 2025; status: active, not recruiting.
02
Drugs
ivabradine
03
Conditions
burn injuryhypermetabolic response to burn injury (HRBI)tachyarrhythmia
Beyond the preview
Go deeper on jRCTs031240390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240390.